Texas Instruments Incorporated : Biote Investor Presentation 2025

Published: 2025-03-27 07:37:06 ET TXN

Transforming Healthy Aging

Looking Forward

Biote by the Numbers1

The Established Leader in Hormone Optimization

1. All information as of December 31, 2024 unless otherwise stated. 2. Adjusted EBITDA and Adjusted EBITDA Margin are non-GAAP financial figures. Please see slides 23-24 for a reconciliation of these measures to their most closely comparable GAAP measures.

Investment Highlights

Why Hormone Optimization

Hormone Deficiency Impacts Quality of Life and Heightens Risk of Chronic Disease

~47M Women

affected with menopausal symptoms(8)

Common symptoms:(1) Hormone deficiency increases risk of:

• Low energy

• Insomnia

• Decreased libido

• Brain fog

• Irritability

• Depression

• Hot flashes/sweats

• Bladder problems

• Heart disease(2)(3)

• Breast cancer(4)(5)

• Osteoporosis(6)

• Neurodegenerative diseases(7)

~20M Men

over age 45 are affected by low testosterone(9)

Biote: A Better Solution for Practitioners & Patients

Our Practitioner Certification Process is rigorous, involving pre-screening, an intensive two-day training program, and continuous education and evaluation in practice

1. As of December 31, 2024.

Biote-certified practitioners customize treatment therapies based on our proprietary algorithms to meet each patient's unique needs and preferences

Our proprietary technology empowers practitioners with a single-source platform, exclusive software solutions and strategic marketing support

A More Proactive and Holistic Approach to Healthcare

Practitioners Seek:

▪ Single-source technology platform

▪ Therapies to address common health conditions

▪ Revenue opportunities that enhance clinic economics

Patients Seek:

▪ Ease and convenience from a single provider

▪ Evidence-based results

▪ Broad range of complementary wellness therapies

Large & Growing Markets

82% of US Consumers Consider Wellness a Top or Important Priority in their Everyday Lives(10)

▪ Growing patient interest in personal health & wellness

▪ Patient desire for evidence-based results

▪ Trend toward preventive medicine

Hormone Deficiency Affects

~200M Americans with 80%(11) Untreated(12)

Significant Geographic & Practitioner Expansion Opportunity1

Building on our success in our core states to efficiently scale our presence

▪ Tech-enabled, franchise-like highly-scalable business model

▪ Added 1,500 Biote-Certified Practitioners in 2024

▪ Accelerated practitioner on-boarding process

▪ ~120 Commercial Team

Green = Emerging Market

1. All information as of December 31, 2024 unless otherwise stated.

2. As of 2019.

Disclaimer

Texas Instruments Incorporated published this content on March 27, 2025, and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on March 27, 2025 at 11:36:02.034.